Page 191 - 2018_12-Haematologica-web

Diffuse alveolar hemorrhage after HCT
26. Nusair S, Breuer R, Shapira MY, Berkman N, Or R. Low incidence of pulmonary com- plications following nonmyeloablative stem cell transplantation. Eur Respir J. 2004;23(3):440-445.
27. Shankar G, Scott Bryson J, Darrell Jennings C, Kaplan AM, Cohen DA. Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice. Role of pretransplant radiation conditioning. Am J Respir Cell Mol Biol. 1999;20(6):1116-1124.
28. Escuissato DL, Warszawiak D, Marchiori E. Differential diagnosis of diffuse alveolar haemorrhage in immunocompromised patients. Curr Opin Infect Dis. 2015;28(4):337-342.
29. Lefrancais E, Ortiz-Munoz G, Caudrillier A, et al. The lung is a site of platelet biogen- esis and a reservoir for haematopoietic pro- genitors. Nature. 2017;544(7648):105-+.
30. Zucker-Franklin D, Philipp CS. Platelet pro- duction in the pulmonary capillary bed: new ultrastructural evidence for an old con- cept. Am J Pathol. 2000;157(1):69-74.
31. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood. 1965;26(6):720-731.
32. Kroll MH, Afshar-Kharghan V. Platelets in pulmonary vascular physiology and pathol- ogy. Pulm Circ. 2012;2(3):291-308.
33. Weisdorf D, Eapen M, Ruggeri A, et al. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for inter- national blood and marrow transplant research-eurocord analysis. Biol Blood Marrow Transplant. 2014;20(6):816-822.
34. Brunstein CG, Fuchs EJ, Carter SL, et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA- mismatched related bone marrow or unre- lated double umbilical cord blood grafts. Blood. 2011;118(2):282-288.
35. Rodrigues CA, Rocha V, Dreger P, et al. Alternative donor hematopoietic stem cell transplantation for mature lymphoid malig- nancies after reduced-intensity condition- ing regimen: similar outcomes with umbil- ical cord blood and unrelated donor periph- eral blood. Haematologica. 2014;99(2):370- 377.
36.
37. 38.
39.
40.
41.
42.
43.
44.
45.
46.
Jillella AP, Ustun C. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant? Stem Cells Dev. 2004;13(6):598-606.
Weisdorf DJ. Diffuse alveolar hemorrhage: an evolving problem? Leukemia. 2003;17(6):1049-1050.
Metcalf JP, Rennard SI, Reed EC, et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am J Med. 1994;96(4):327-334.
Chan CK, Hyland RH, Hutcheon MA. Pulmonary complications following bone marrow transplantation. Clin Chest Med. 1990;11(2):323-332.
Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respiratory distress syn- drome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27(12):1299-1303.
Pena E, Souza CA, Escuissato DL, et al. Noninfectious pulmonary complications after hematopoietic stem cell transplanta- tion: practical approach to imaging diagno- sis. Radiographics. 2014;34(3):663-683. Wanko SO, Broadwater G, Folz RJ, Chao NJ. Diffuse alveolar hemorrhage: retrospec- tive review of clinical outcome in allogene- ic transplant recipients treated with aminocaproic acid. Biol Blood Marrow Transplant. 2006;12(9):949-953.
Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(4):223-229.
Sisson JH, Thompson AB, Anderson JR, et al. Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease. Am Rev Respir Dis. 1992;146(2):439-443.
Graf L, Stern M. Acute phase after haematopoietic stem cell transplantation: bleeding and thrombotic complications. Hamostaseologie. 2012;32(1):56-62.
Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, et al. Randomized, double-blind, placebo-con-
trolled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treat- ment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. Biol Blood Marrow Transplant. 2014;20(6):858-864.
47. Rathi NK, Tanner AR, Dinh A, et al. Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage. Bone Marrow Transplant. 2015;50(3):420-426.
48. Heslet L, Nielsen JD, Levi M, Sengelov H, Johansson PI. Successful pulmonary admin- istration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care. 2006;10(6):R177.
49. Estella A, Jareno A, Perez-Bello Fontaina L. Intrapulmonary administration of recombi- nant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories. Cases J. 2008;1(1):150.
50. Antin JH, Weisdorf D, Neuberg D, et al. Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-con- trolled trial of interleukin-1 receptor antag- onist in allogeneic bone marrow transplan- tation. Blood. 2002;100(10):3479-3482.
51. Raptis A, Mavroudis D, Suffredini A, Molldrem J, Rhee FV, Childs R, et al. High- dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients. Bone Marrow Transplant. 1999;24(8):879- 883.
52. Srivastava A, Gottlieb D, Bradstock KF. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;15(6):863-867.
53. Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med. 2000;28(4):1014-1017.
54. Lewis ID, DeFor T, Weisdorf DJ. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow trans- plantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant. 2000;26(5):539-543.
haematologica | 2018; 103(12)
2115